Kennedy Martin Health Outcomes Limited - Period Ending 2019-03-31

Kennedy Martin Health Outcomes Limited - Period Ending 2019-03-31


Kennedy Martin Health Outcomes Limited 05743972 false 2018-04-01 2019-03-31 2019-03-31 The principal activity of the company is to provide consultancy and to carry out research into drugs and food Digita Accounts Production Advanced 6.24.8820.0 Software true 05743972 2018-04-01 2019-03-31 05743972 2019-03-31 05743972 bus:CompanySecretaryDirector1 1 2019-03-31 05743972 bus:Director2 1 2019-03-31 05743972 bus:OrdinaryShareClass1 2019-03-31 05743972 core:CurrentFinancialInstruments 2019-03-31 05743972 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 05743972 core:FurnitureFittings 2019-03-31 05743972 core:OfficeEquipment 2019-03-31 05743972 core:OtherPropertyPlantEquipment 2019-03-31 05743972 bus:SmallEntities 2018-04-01 2019-03-31 05743972 bus:AuditExemptWithAccountantsReport 2018-04-01 2019-03-31 05743972 bus:FullAccounts 2018-04-01 2019-03-31 05743972 bus:SmallCompaniesRegimeForAccounts 2018-04-01 2019-03-31 05743972 bus:RegisteredOffice 2018-04-01 2019-03-31 05743972 bus:CompanySecretaryDirector1 2018-04-01 2019-03-31 05743972 bus:CompanySecretaryDirector1 1 2018-04-01 2019-03-31 05743972 bus:Director2 2018-04-01 2019-03-31 05743972 bus:Director2 1 2018-04-01 2019-03-31 05743972 bus:OrdinaryShareClass1 2018-04-01 2019-03-31 05743972 bus:PrivateLimitedCompanyLtd 2018-04-01 2019-03-31 05743972 core:FurnitureFittings 2018-04-01 2019-03-31 05743972 core:OfficeEquipment 2018-04-01 2019-03-31 05743972 core:OtherPropertyPlantEquipment 2018-04-01 2019-03-31 05743972 core:PlantMachinery 2018-04-01 2019-03-31 05743972 countries:AllCountries 2018-04-01 2019-03-31 05743972 2018-03-31 05743972 bus:CompanySecretaryDirector1 1 2018-03-31 05743972 bus:Director2 1 2018-03-31 05743972 core:FurnitureFittings 2018-03-31 05743972 core:OfficeEquipment 2018-03-31 05743972 core:OtherPropertyPlantEquipment 2018-03-31 05743972 2017-04-01 2018-03-31 05743972 2018-03-31 05743972 bus:CompanySecretaryDirector1 1 2018-03-31 05743972 bus:Director2 1 2018-03-31 05743972 bus:OrdinaryShareClass1 2018-03-31 05743972 core:CurrentFinancialInstruments 2018-03-31 05743972 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-31 05743972 core:CurrentFinancialInstruments core:WithinOneYear core:RestatedAmount 2018-03-31 05743972 core:CurrentFinancialInstruments core:RestatedAmount 2018-03-31 05743972 core:FurnitureFittings 2018-03-31 05743972 core:OfficeEquipment 2018-03-31 05743972 core:OtherPropertyPlantEquipment 2018-03-31 05743972 core:RestatedAmount 2018-03-31 05743972 bus:CompanySecretaryDirector1 1 2017-04-01 2018-03-31 05743972 bus:Director2 1 2017-04-01 2018-03-31 05743972 bus:CompanySecretaryDirector1 1 2017-03-31 05743972 bus:Director2 1 2017-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05743972

Kennedy Martin Health Outcomes Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2019

X5 Chartered Accountants
2 Upperton Gardens
Eastbourne
East Sussex
BN21 2AH


 

 

Kennedy Martin Health Outcomes Limited

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 10

 

Kennedy Martin Health Outcomes Limited

Company Information

Directors

Mr Matthew Jason Kennedy-Martin

Mrs Tessa Adeline Kennedy-Martin

Company secretary

Mr Matthew Jason Kennedy-Martin

Registered office

Suite 404
The Dock Hub
Wilbury Villas
Hove
East Sussex
BN3 6AH

Accountants

X5 Chartered Accountants
2 Upperton Gardens
Eastbourne
East Sussex
BN21 2AH

 

Kennedy Martin Health Outcomes Limited

Directors' Report for the Year Ended 31 March 2019

The directors present their report and the financial statements for the year ended 31 March 2019.

Directors of the company

The directors who held office during the year were as follows:

Mr Matthew Jason Kennedy-Martin - Company secretary and director

Mrs Tessa Adeline Kennedy-Martin

Principal activity

The principal activity of the company is to provide consultancy and to carry out research into drugs and food

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the Board on 10 December 2019 and signed on its behalf by:

.........................................
Mr Matthew Jason Kennedy-Martin
Company secretary and director

.........................................
Mrs Tessa Adeline Kennedy-Martin
Director

 

Kennedy Martin Health Outcomes Limited

(Registration number: 05743972)
Balance Sheet as at 31 March 2019

Note

2019
£

(As restated)

2018
£

Fixed assets

 

Tangible assets

4

8,125

6,919

Current assets

 

Debtors

5

55,674

33,831

Cash at bank and in hand

 

97,871

226,439

 

153,545

260,270

Creditors: Amounts falling due within one year

6

(101,928)

(77,306)

Net current assets

 

51,617

182,964

Total assets less current liabilities

 

59,742

189,883

Provisions for liabilities

(1,543)

(1,314)

Net assets

 

58,199

188,569

Capital and reserves

 

Called up share capital

7

100

100

Profit and loss account

58,099

188,469

Total equity

 

58,199

188,569

For the financial year ending 31 March 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 10 December 2019 and signed on its behalf by:
 

 

Kennedy Martin Health Outcomes Limited

(Registration number: 05743972)
Balance Sheet as at 31 March 2019

.........................................

Mr Matthew Jason Kennedy-Martin
Company secretary and director

.........................................

Mrs Tessa Adeline Kennedy-Martin
Director

 

Kennedy Martin Health Outcomes Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Suite 404
The Dock Hub
Wilbury Villas
Hove
East Sussex
BN3 6AH

The principal place of business is:
Suite 404
The Dock Hub
Wilbury Villas
Hove
East Sussex
BN3 6AH

These financial statements were authorised for issue by the Board on 10 December 2019.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Kennedy Martin Health Outcomes Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% reducing balance method

Fixtures & Fittings

25% reducing balance method

Computer equipment

33% straight line method

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Kennedy Martin Health Outcomes Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2018 - 2).

 

Kennedy Martin Health Outcomes Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

4

Tangible assets

Fixtures and fittings
£

Office equipment
£

Other tangible assets
 £

Total
£

Cost or valuation

At 1 April 2018

17,398

46,959

14,661

79,018

Additions

-

5,552

-

5,552

At 31 March 2019

17,398

52,511

14,661

84,570

Depreciation

At 1 April 2018

14,322

44,786

12,991

72,099

Charge for the year

769

3,243

334

4,346

At 31 March 2019

15,091

48,029

13,325

76,445

Carrying amount

At 31 March 2019

2,307

4,482

1,336

8,125

At 31 March 2018

3,076

2,173

1,670

6,919

5

Debtors

2019
£

(As restated)

2018
£

Trade debtors

53,440

18,993

Prepayments

297

8,756

Other debtors

1,937

6,082

55,674

33,831

6

Creditors

Creditors: amounts falling due within one year

 

Kennedy Martin Health Outcomes Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

Note

2019
£

(As restated)

2018
£

Due within one year

 

Loans and borrowings

8

-

47

Trade creditors

 

226

10,327

Taxation and social security

 

92,287

66,109

Accruals and deferred income

 

190

190

Other creditors

 

9,225

633

 

101,928

77,306

7

Share capital

Allotted, called up and fully paid shares

 

2019

2018

 

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

         
 

Kennedy Martin Health Outcomes Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

8

Loans and borrowings

2019
£

2018
£

Current loans and borrowings

Bank overdrafts

-

47

9

Dividends

   

2019

 

2018

   

£

 

£

Interim dividend of £5,050 (2018 - £2,175) per ordinary share

 

505,000

 

217,500

         

10

Related party transactions

Transactions with directors

2019

At 1 April 2018
£

Advances to directors
£

Repayments by director
£

At 31 March 2019
£

Mr Matthew Jason Kennedy-Martin

923

(237,224)

238,527

2,226

         
       

Mrs Tessa Adeline Kennedy-Martin

923

(301,971)

303,275

2,226

         
       

 

2018

At 1 April 2017
£

Advances to directors
£

Repayments by director
£

At 31 March 2018
£

Mr Matthew Jason Kennedy-Martin

1,507

(235,567)

234,983

923

         
       

Mrs Tessa Adeline Kennedy-Martin

1,507

(223,153)

222,569

923

         
       

 

Directors' remuneration

The directors' remuneration for the year was as follows:

2019
£

2018
£

Remuneration

8,000

8,000